| Bioactivity | PPARα/γ agonist 5 is a dual PPARα/γ agonist with significant biological activity exhibited at low concentrations. The EC50 of PPARα/γ agonist 5 are 0.358μM and 1.21μM respectively, showing its potential in inhibiting type 2 diabetes and lipid metabolism disorders. PPARα/γ agonist 5 was selected for clinical development due to its high efficacy[1]. |
| CAS | 849150-59-0 |
| Formula | C24H23NO5S |
| Molar Mass | 437.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Aleglitazar, a new, potent, and balanced dual PPARa/c agonist for the treatment of type II diabetes |
PPARα/γ agonist 5
CAS: 849150-59-0 F: C24H23NO5S W: 437.51
PPARα/γ agonist 5 is a dual PPARα/γ agonist with significant biological activity exhibited at low concentrations. Th
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.